Salcaprozate Sodium: Enhancing Intestinal Permeation for Oral Drug Delivery of Macromolecules
Revolutionizing oral drug delivery by enhancing intestinal permeation for better bioavailability.
Get a Quote & SampleProduct Core Value
Salcaprozate Sodium
Salcaprozate sodium is a cutting-edge intestinal permeation enhancer designed to significantly boost the oral delivery of macromolecules and compounds with poor permeability. Its unique mechanism involves increasing lipophilicity via non-covalent macromolecular complexation, which consequently enhances passive transcellular permeation across intestinal epithelial cells.
- Leveraging Salcaprozate sodium intestinal permeation enhancer technology for improved oral drug delivery.
- Achieve enhanced passive transcellular permeation of intestinal epithelial cells for better absorption.
- The power of non-covalent macromolecular complexation in increasing lipophilicity for drug formulation.
- Explore the benefits of Salcaprozate sodium in oral semaglutide formulations for human use.
Key Advantages
Enhanced Bioavailability
Salcaprozate sodium is instrumental in improving oral bioavailability, a critical factor for effective drug therapy when using oral semaglutide formulations.
Facilitates Macromolecule Delivery
This excipient is crucial for enabling the oral administration of macromolecules, which traditionally faced significant delivery challenges.
Safety and Regulatory Approval
With its GRAS status and FDA approval for medical food products, Salcaprozate sodium offers a reliable and safe option for drug formulation.
Key Applications
Oral Drug Delivery
Salcaprozate sodium's primary role is to enhance the oral absorption of various drugs, particularly peptides and other large molecules.
Medical Foods
Its FDA approval for medical food products highlights its safety and versatility in health-related applications.
Pharmaceutical Formulations
Used as a critical excipient to improve the lipophilicity and permeation characteristics of drug products.
Biopharmaceutical Delivery
Aids in the development of more effective delivery systems for biopharmaceuticals, overcoming oral absorption barriers.